AC Immune Ltd (ACIU) Receives New Coverage from Analysts at Leerink Swann
Equities researchers at Leerink Swann started coverage on shares of AC Immune Ltd (NASDAQ:ACIU) in a note issued to investors on Tuesday, The Fly reports. The firm set an “outperform” rating on the stock.
Several other research firms also recently commented on ACIU. Credit Suisse Group AG assumed coverage on shares of AC Immune in a report on Tuesday. They issued an “outperform” rating on the stock. Jefferies Group assumed coverage on shares of AC Immune in a report on Tuesday. They issued a “buy” rating on the stock.
Shares of AC Immune (NASDAQ:ACIU) opened at 14.43 on Tuesday. AC Immune has a 52-week low of $13.01 and a 52-week high of $19.97. The stock has a market capitalization of $712.78 million and a PE ratio of 31.17. The stock has a 50 day moving average of $16.17 and a 200 day moving average of $16.17.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/18/ac-immune-ltd-aciu-receives-new-coverage-from-analysts-at-leerink-swann.html
Receive News & Ratings for AC Immune Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AC Immune Ltd and related companies with MarketBeat.com's FREE daily email newsletter.